Xencor Inc - Has Been Notified That Janssen Will Terminate Its Rights to Plamotamab Under Collaboration and License Agreement
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.